Tabla de Contenidos: “…Contraceptive Research, Introduction, and Use -- Copyright -- Acknowledgments -- Contents -- 1 Introduction -- 2 Workshop Report -- EFFICACY AND SAFETY -- Efficacy -- Safety -- Major Health-Related Events -- Significant Health-Related Problems -- Silicone Biocompatibility -- Progestin Effects on Vaginal HIV Transmission -- WHO USES NORPLANT AND HOW -- User Populations -- Method Continuation and Discontinuation -- Side Effects as Factors -- User Satisfaction -- Barriers to Discontinuation -- Cost and Cost-Effectiveness -- Effects of Media Coverage and Litigation on Norplant Use -- INSERTION AND REMOVAL: EXPERIENCE AND IMPLICATIONS -- Technical Aspects -- Case Experiences -- Rates of Complicated Removals -- Implications -- CONSUMER PERSPECTIVES -- Communication and Quality of Care -- Quality of Care -- Informed Decision-Making -- Importance -- Content -- Special Challenges -- Potential for Abuse -- Consumer Involvement -- NEW APPROACHES -- Reproductive Health Technologies Project's "Boom and Bust Initiative -- The WHO Strategic Approach to Contraceptive Introduction -- A ''Government Standards Defense -- 3 Workshop Summary and Analysis -- DATA REVIEW -- Efficacy -- Safety -- User Profiles -- Side Effects -- Continuation and Discontinuation -- User Satisfaction -- Postmarketing Surveillance -- Cost-Effectiveness -- LESSONS LEARNED -- NEXT STEPS: AREAS FOR CONSIDERATION AND ACTION -- Areas for Strengthening or Expansion -- 1. …”

Tabla de Contenidos: “…Congregation and Coordination of Related Lawsuits Settlements of Mass Torts; CHAPTER FOUR: Pharmaceutical Mass Torts During the 1990's and 2000's; Mass Torts Resulting in Especially Large Payouts by Defendants; Fen-Phen Diet Pills; Baycol; Rezulin; Vioxx; Hormone Replacement Therapies-Premarin, Provera, and Prempro; Zyprexa; Mass Tort Attempts Resulting in Substantially Smaller Payouts by Defendants; Norplant; Childhood Vaccines and Autism; Other Mass Tort Attempts That Have Largely Failed for Plaintiffs; Summing Up; Mass Drug-Related Injuries; Mass Torts; Financial Incentives to Avoid Liability…”